Patents by Inventor Joyce A. Pritchard

Joyce A. Pritchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant NDV antigen and uses thereof
    Patent number: 10633667
    Abstract: The present invention encompasses NDV vaccines. The vaccine may be a subunit vaccine based on HN of NDV. The NDV HN may be expressed in plants or algae including microalgae. The invention also encompasses recombinant vectors encoding and expressing NDV antigens, epitopes or immunogens which can be used to protect animals against NDV. It encompasses also a vaccination regime compatible with the DIVA strategy, including a prime-boost scheme using viral vector or inactivated vaccines and subunit vaccines.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 28, 2020
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Xuan Guo, Karolyn Marie Troupe, Bradley J. Feilmeier, Joyce A. Pritchard, Julio Sergio Cruz-Coy
  • Production of hemagglutinin-neuraminidase protein in microalgae
    Patent number: 9012197
    Abstract: The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 21, 2015
    Assignees: Merial, Inc., Sanofi Vaccine Technologies, S.A.S.
    Inventors: Anne-Cécile V. Bayne, James Casey Lippmeier, Kirk Emil Apt, Xuan Guo, Joyce A. Pritchard
  • Recombinant avian influenza vaccine and uses thereof
    Patent number: 8394384
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: March 12, 2013
    Assignees: Merial Limited, Biolex Therapeutics, Inc.
    Inventors: Xuan Guo, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey
  • PRODUCTION OF HEMAGGLUTININ-NEURAMINIDASE PROTEIN IN MICROALGAE
    Publication number: 20110195480
    Abstract: The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
    Type: Application
    Filed: December 28, 2010
    Publication date: August 11, 2011
    Inventors: Anne-Cécile V. Bayne, James Casey Lippmeier, Kirk Emil APT, Xuan Guo, Joyce A. Pritchard
  • RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF
    Publication number: 20100189731
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Application
    Filed: November 30, 2009
    Publication date: July 29, 2010
    Inventors: Xuan GUO, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey